Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (9 ops.)
Latest filing published 23 Jan 2026 for Soleno Therapeutics INC. Read the official filing
Filing timeline
BuySaleJames H. Mackaness
Insider track record
Disclosed buys
3
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-14.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
James H. Mackaness: trading record in brief
James H. Mackaness, listed as finance chief, appears in our data through filings on Soleno Therapeutics Inc shares, published by SEC (Form 4). In total, 20 filings cover trades dated from 26 June 2020 to 21 January 2026.
In open-market terms, that means 3 purchases worth €17k on one side and 9 sales worth €1.3M on the other. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 2 option exercises.
The latest filing, published on 23 January 2026, reports a share grant in Soleno Therapeutics Inc. The clock since the last published purchase (4 April 2022) now reads 1,658 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James H. Mackaness
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
28,600 shares0Common StockSEC:0001422484-26-000001:0
2,013 shares@ US$49.956.0% of flowCommon StockSEC:0001422484-25-000003:0
1,669 shares@ US$65.96917.6% of flowCommon StockSEC:0001415889-25-009295:0
14,500 shares0Common StockSEC:0001415889-25-001935:0
3,762 shares@ US$45.365612.2% of flowCommon StockSEC:0001415889-25-000955:0
7,248 shares@ US$49.335823.9% of flowCommon StockSEC:0001415889-24-024664:0
3,561 shares@ US$47.192611.2% of flowCommon StockSEC:0001415889-24-022650:0
3,858 shares@ US$45.476711.9% of flowCommon StockSEC:0001415889-24-020945:0
100,000 shares0Common StockSEC:0001415889-24-019808:0
1,568 shares@ US$41.22174.5% of flowCommon StockSEC:0001415889-24-019269:0
3,104 shares@ US$41.12278.8% of flowCommon StockSEC:0001415889-24-010247:0
56,000 shares0Common StockSEC:0001209191-24-001176:0
2,666 shares@ US$4.500.8% of flowCommon StockSEC:0001209191-23-058574:0
15,000 shares@ US$2.5952.7% of flowCommon StockSEC:0001209191-23-058576:0
4,186 shares@ US$28.65198.1% of flowCommon StockSEC:0001209191-23-057320:0
3,205 shares@ US$27.02625.8% of flowCommon StockSEC:0001209191-23-057036:0
29,084 shares0Common StockSEC:0001209191-23-032694:0
40,000 sharesCommon StockSEC:0000899243-22-013308:0
Canonical exit: 29 Jun 2022 (T+90)
6,060 shares@ US$1.650.0003% mcap25.7% of flowCommon StockSEC:0000899243-21-035862:0
Canonical exit: 24 Sept 2020 (T+90)
11,235 shares@ US$0.88840.6% of flowCommon StockSEC:0000899243-21-035864:0
Canonical exit: 12 Dec 2021 (T+90)
20 of 20 declarations
